Abstract
At micromolar concentrations, many small molecules self-associate into colloidal aggregates that non-specifically inhibit enzymes and other proteins. Here we describe a protocol for identifying aggregate-based inhibitors and distinguishing them from small molecules that inhibit via specific mechanisms. As a convenient proxy for promiscuous, aggregate-based inhibition, we monitor inhibition of β-lactamase in the absence and presence of detergent. Inhibition that is attenuated in the presence of detergent is characteristic of an aggregate-based mechanism. In the 96-well-format assay described here, about 200 molecules can be tested, in duplicate, per hour for detergent-dependent sensitivity. Furthermore, we also describe simple experiments that can offer additional confirmation of aggregate-based inhibition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hajduk, P.J., Huth, J.R. & Fesik, S.W. Druggability indices for protein targets derived from NMR-based screening data. J. Med. Chem. 48, 2518–2525 (2005).
Rishton, G.M. Reactive compounds and in vitro false positives in HTS. Drug Discov. Today 2, 382–384 (1997).
Walters, W.P. & Namchuk, M. Designing screens: how to make your hits a hit. Nat. Rev. Drug Discov. 2, 259–266 (2003).
Feng, B. & Shoichet, B.K. Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures. J. Med. Chem. 49, 2151–2154 (2006).
Feng, B.Y. et al. High-throughput assays for promiscuous inhibitors. Nat. Chem. Biol. 1, 146–148 (2005).
McGovern, S.L., Caselli, E., Grigorieff, N. & Shoichet, B.K. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem. 45, 1712–1722 (2002).
McGovern, S.L., Helfand, B.T., Feng, B.Y. & Shoichet, B.K. A specific mechanism of nonspecific inhibition. J. Med. Chem. 46, 4265–4272 (2003).
McGovern, S.L. & Shoichet, B.K. Kinase inhibitors: not just for kinases anymore. J. Med. Chem. 46, 1478–1483 (2003).
Seidler, J., McGovern, S.L., Doman, T. & Shoichet, B.K. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 46, 4477–4486 (2003).
Seidler, J., McGovern, S.L., Doman, T.N. & Shoichet, B.K. Identification and prediction of promiscuous drugs. J. Med. Chem. 46, 4477–4486 (2003).
Weston, G.S., Blazquez, J., Baquero, F. & Shoichet, B.K. Structure-based enhancement of boronic acid-based inhibitors of AmpC β-lactamase. J. Med. Chem. 41, 4577–4586 (1998).
Ryan, A.J., Gray, N.M., Lowe, P.N. & Chung, C. Effect of detergent on 'promiscuous' inhibitors. J. Med. Chem. 46, 3448–3451 (2003).
Straus, O.H. & Goldstein, A. Zone behavior of enzymes: illustrated by the effect of dissociation constant and dilution on the system cholinesterase–physostigmine. J. Gen. Physiol. 26, 559–585 (1943).
Acknowledgements
We thank A. McReynolds and K. Coan for reading this manuscript, K.C. for thoughtful discussions and GM71630.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Feng, B., Shoichet, B. A detergent-based assay for the detection of promiscuous inhibitors. Nat Protoc 1, 550–553 (2006). https://doi.org/10.1038/nprot.2006.77
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2006.77
This article is cited by
-
Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro
Chinese Medicine (2023)
-
Reference compounds for characterizing cellular injury in high-content cellular morphology assays
Nature Communications (2023)
-
Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria
Scientific Reports (2022)
-
Probing the free-state solution behavior of drugs and their tendencies to self-aggregate into nano-entities
Nature Protocols (2021)
-
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
Protein & Cell (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.